510(k) Report

510(k) · Cleared

Cleared

CAPRI

K254271510(k) TraditionalCleared Feb 26, 202658-day reviewClass II21 CFR 878.4810

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

ORO Co., Ltd. · GEX Powered Laser Surgical Instrument

Cleared on Feb 26, 2026 as substantially equivalent to K041242 (Candela Corp., 2004) after a 58-day review. Its family tree reaches back 5 generations to 2000.

Decided
Feb 26, 2026
Review
58 days
Class
Class II
Product code
GEX
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K002421 (2000). 6 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 5 generations backK002421 Candela Mid IR Diode Laser SystemCandela Corp. · 2000
  2. 4 generations backK013825 Candela Smoothbeam Laser SystemCandela Corp. · 2002 · Recalled
  3. 3 generations backK022884 Candela Smoothbeam Laser SystemCandela Corp. · 2003 · Recalled
  4. 2 generations backK030834 Candela Smoothbeam Laser SystemCandela Corp. · 2003 · Recalled
  5. 1 generation backK041242 Candela Smoothbeam Laser SystemCandela Corp. · 2004
  6. This deviceK254271 CAPRIORO Co., Ltd. · 2026
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K002421Candela Mid IR Diode Laser SystemCandela Corp.2000—
−4K013825Candela Smoothbeam Laser SystemCandela Corp.20021
−3K022884Candela Smoothbeam Laser SystemCandela Corp.20031
−2K030834Candela Smoothbeam Laser SystemCandela Corp.20031
−1K041242Candela Smoothbeam Laser SystemCandela Corp.2004—
0 (this device)K254271CAPRIORO Co., Ltd.2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110
FIG. 1 — Lineage of K254271, 2000–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GEX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GEX device

  1. #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K041242Candela Smoothbeam Laser System
Summary page 5
…surgical instrument for use in general and plastic surgery and in dermatology Regulation Number: 878.4810 Regulatory Class: II Product Code: GEX III. PREDICATE DEVICE K041242, Candela Smoothbeam Laser System, GEX No reference devices were used in this submission. IV. DEVICE DESCRIPTION CAPRI is a diod…
Candela Corp.2004—

Also cleared against K041242: 4 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 26 years and passes through 2 companies; a new generation was cleared every 12 months on median.
  • 3 of the 6 ancestors have a recall of any class.
  • 4 other devices also cite its predicate K041242.

How does its category compare?

All GEX devices

GEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · GEX

83in 2025

2007: 732008: 1072009: 692010: 502011: 412012: 452013: 462014: 612015: 472016: 512017: 672018: 512019: 412020: 522021: 532022: 602023: 522024: 822025: 832026 (partial year): 57
2007high 107 (2008) · low 41 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GEX

90in 2025

2007: 79 days median2008: 86 days median2009: 100 days median2010: 96 days median2011: 83 days median2012: 118 days median2013: 144 days median2014: 147 days median2015: 112 days median2016: 114 days median2017: 90 days median2018: 78 days median2019: 88 days median2020: 90 days median2021: 123 days median2022: 152 days median2023: 87 days median2024: 90 days median2025: 90 days median2026 (partial year): 90 days median
2007high 152 (2022) · low 78 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GEX

3in 2024

2007: 92008: 22010: 42011: 182012: 52013: 32014: 62016: 12017: 5, 1 Class I2018: 52019: 62020: 12023: 62024: 32026 (partial year): 2
2007high 18 (2011) · low 0 (2009)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · GEX

2,720in 2025

2007: 3422008: 2322009: 2092010: 1,7112011: 3,0242012: 2,0002013: 2,2362014: 2,0362015: 2,0992016: 2,5852017: 2,9772018: 3,5252019: 2,7092020: 2,1832021: 3,4652022: 2,2882023: 2,3372024: 2,1872025: 2,720
2007high 3,525 (2018) · low 209 (2009)2025

MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200773799342
2008107862232
2009691000209
2010509641,711
20114183183,024
20124511852,000
20134614432,236
20146114762,036
20154711202,099
20165111412,585
201767905 (1)2,977
2018517853,525
2019418862,709
2020529012,183
20215312303,465
20226015202,288
2023528762,337
2024829032,187
2025839002,720
202657902—

What is it indicated for?

CAPRI is indicated for use in dermatology: incision, excision, ablation, and vaporization with hemostasis of soft tissue,

Treatment of back acne

Treatment of atrophic acne scars

Treatment of facial wrinkles

Treatment of mild to moderate acne vulgaris

Treatment of Sebaceous Hyperplasia.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K254271: CAPRI.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K254271

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026